Integrative transcriptomic analysis of tissue-specific metabolic crosstalk after myocardial infarction

  1. Muhammad Arif
  2. Martina Klevstig
  3. Rui Benfeitas
  4. Stephen Doran
  5. Hasan Turkez
  6. Mathias Uhlén
  7. Maryam Clausen
  8. Johannes Wikström
  9. Damla Etal
  10. Cheng Zhang
  11. Malin Levin
  12. Adil Mardinoglu  Is a corresponding author
  13. Jan Boren  Is a corresponding author
  1. KTH Royal Institute of Technology, Sweden
  2. University of Gothenburg, Sweden
  3. KTH - Royal Institute of Technology, Sweden
  4. King's College London, United Kingdom
  5. Atatürk University, Turkey
  6. AstraZeneca, Sweden

Abstract

Myocardial infarction (MI) promotes a range of systemic effects, many of which are unknown. Here, we investigated the alterations associated with MI progression in heart and other metabolically active tissues (liver, skeletal muscle, and adipose) in a mouse model of MI (induced by ligating the left ascending coronary artery) and sham-operated mice. We performed a genome-wide transcriptomic analysis on tissue samples obtained 6- and 24-hours post MI or sham operation. By generating tissue-specific biological networks, we observed: (1) dysregulation in multiple biological processes (including immune system, mitochondrial dysfunction, fatty-acid beta-oxidation, and RNA and protein processing) across multiple tissues post MI; and (2) tissue-specific dysregulation in biological processes in liver and heart post MI. Finally, we validated our findings in two independent MI cohorts. Overall, our integrative analysis highlighted both common and specific biological responses to MI across a range of metabolically active tissues.

Data availability

All raw RNA-sequencing data generated from this study can be accessed through accession number GSE153485.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Muhammad Arif

    Systems Biology, KTH Royal Institute of Technology, Stockholm, Sweden
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2261-0881
  2. Martina Klevstig

    Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden
    Competing interests
    No competing interests declared.
  3. Rui Benfeitas

    Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7972-0083
  4. Stephen Doran

    Centre for Host-Microbiome Interactions, King's College London, London, United Kingdom
    Competing interests
    No competing interests declared.
  5. Hasan Turkez

    Department of Medical Biology, Atatürk University, Erzurum, Turkey
    Competing interests
    No competing interests declared.
  6. Mathias Uhlén

    Systems Biology, KTH Royal Institute of Technology, Stockholm, Sweden
    Competing interests
    No competing interests declared.
  7. Maryam Clausen

    Discovery Sciences, Innovative Medicines and Early Development Biotech unit, AstraZeneca, Mölndal, Sweden
    Competing interests
    Maryam Clausen, employee at AstraZeneca.
  8. Johannes Wikström

    Bioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca, Gothenburg, Sweden
    Competing interests
    Johannes Wikström, employee at AstraZeneca.
  9. Damla Etal

    Translational Genomics, AstraZeneca, Gothenburg, Sweden
    Competing interests
    Damla Etal, employee at AstraZeneca.
  10. Cheng Zhang

    Systems Biology, KTH Royal Institute of Technology, Stockholm, Sweden
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3721-8586
  11. Malin Levin

    Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden
    Competing interests
    No competing interests declared.
  12. Adil Mardinoglu

    Systems Biology, KTH Royal Institute of Technology, Stockholm, Sweden
    For correspondence
    adil.mardinoglu@kcl.ac.uk
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4254-6090
  13. Jan Boren

    Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden
    For correspondence
    Jan.Boren@wlab.gu.se
    Competing interests
    No competing interests declared.

Funding

Knut och Alice Wallenbergs Stiftelse

  • Adil Mardinoglu
  • Jan Boren

Vetenskapsrådet

  • Jan Boren

Hjärt-Lungfonden

  • Jan Boren

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study were approved by the local animal ethics committee and conform to the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals used for scientific purposes.

Copyright

© 2021, Arif et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Muhammad Arif
  2. Martina Klevstig
  3. Rui Benfeitas
  4. Stephen Doran
  5. Hasan Turkez
  6. Mathias Uhlén
  7. Maryam Clausen
  8. Johannes Wikström
  9. Damla Etal
  10. Cheng Zhang
  11. Malin Levin
  12. Adil Mardinoglu
  13. Jan Boren
(2021)
Integrative transcriptomic analysis of tissue-specific metabolic crosstalk after myocardial infarction
eLife 10:e66921.
https://doi.org/10.7554/eLife.66921

Share this article

https://doi.org/10.7554/eLife.66921

Further reading

    1. Computational and Systems Biology
    2. Medicine
    Hong Yang, Cheng Zhang ... Adil Mardinoglu
    Research Article

    Excessive consumption of sucrose, in the form of sugar-sweetened beverages, has been implicated in the pathogenesis of metabolic dysfunction‐associated fatty liver disease (MAFLD) and other related metabolic syndromes. The c-Jun N-terminal kinase (JNK) pathway plays a crucial role in response to dietary stressors, and it was demonstrated that the inhibition of the JNK pathway could potentially be used in the treatment of MAFLD. However, the intricate mechanisms underlying these interventions remain incompletely understood given their multifaceted effects across multiple tissues. In this study, we challenged rats with sucrose-sweetened water and investigated the potential effects of JNK inhibition by employing network analysis based on the transcriptome profiling obtained from hepatic and extrahepatic tissues, including visceral white adipose tissue, skeletal muscle, and brain. Our data demonstrate that JNK inhibition by JNK-IN-5A effectively reduces the circulating triglyceride accumulation and inflammation in rats subjected to sucrose consumption. Coexpression analysis and genome-scale metabolic modeling reveal that sucrose overconsumption primarily induces transcriptional dysfunction related to fatty acid and oxidative metabolism in the liver and adipose tissues, which are largely rectified after JNK inhibition at a clinically relevant dose. Skeletal muscle exhibited minimal transcriptional changes to sucrose overconsumption but underwent substantial metabolic adaptation following the JNK inhibition. Overall, our data provides novel insights into the molecular basis by which JNK inhibition exerts its metabolic effect in the metabolically active tissues. Furthermore, our findings underpin the critical role of extrahepatic metabolism in the development of diet-induced steatosis, offering valuable guidance for future studies focused on JNK-targeting for effective treatment of MAFLD.

    1. Computational and Systems Biology
    Jun Ren, Ying Zhou ... Qiyuan Li
    Research Article

    Manifold-learning is particularly useful to resolve the complex cellular state space from single-cell RNA sequences. While current manifold-learning methods provide insights into cell fate by inferring graph-based trajectory at cell level, challenges remain to retrieve interpretable biology underlying the diverse cellular states. Here, we described MGPfactXMBD, a model-based manifold-learning framework and capable to factorize complex development trajectories into independent bifurcation processes of gene sets, and thus enables trajectory inference based on relevant features. MGPfactXMBD offers a more nuanced understanding of the biological processes underlying cellular trajectories with potential determinants. When bench-tested across 239 datasets, MGPfactXMBD showed advantages in major quantity-control metrics, such as branch division accuracy and trajectory topology, outperforming most established methods. In real datasets, MGPfactXMBD recovered the critical pathways and cell types in microglia development with experimentally valid regulons and markers. Furthermore, MGPfactXMBD discovered evolutionary trajectories of tumor-associated CD8+ T cells and yielded new subtypes of CD8+ T cells with gene expression signatures significantly predictive of the responses to immune checkpoint inhibitor in independent cohorts. In summary, MGPfactXMBD offers a manifold-learning framework in scRNA-seq data which enables feature selection for specific biological processes and contributing to advance our understanding of biological determination of cell fate.